Seelos Therapeutics Added to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes
NEW YORK, June 28, 2021 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced it has been added to the…
